Form 4 for AORT ARTIVION, INC.
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-17 · accession 0000784199-22-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-17 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | F - Tax | $17.50 | -772 | 11.3K | -6% | -$13.5K | |
| 2022-02-22 | 2022-02-17 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +2,603 | 12.1K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-17 | F | D | 772 | $17.50 | 11,342 | D | — | — | (F2) These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. |
| 2 | Common | Common Stock | 2022-02-17 | A | A | 2,603 | $0.00 | 12,114 | D | — | — | (F1) Represents performance stock units granted on Feb 17, 2021. Hundred percent (100%) were issued on Feb 17, 2022. |